Compare Quest Diagnostics Inc (DGX) vs Invesco WilderHill Clean Energy ETF (PBW) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Quest Diagnostics Inc vs Invesco WilderHill Clean Energy ETF — how do they compare? Quest Diagnostics Inc trades at $205.45 (market cap $22.80B), while Invesco WilderHill Clean Energy ETF trades at $34.98. The key difference: Quest Diagnostics Inc pays a 1.67% dividend while Invesco WilderHill Clean Energy ETF pays none, and Quest Diagnostics Inc is trading nearer its 52-week high, Invesco WilderHill Clean Energy ETF nearer its low. Which is the better fit depends on your goals.
| DGX | PBW | |
|---|---|---|
Market Cap | $22.80B | — |
Sector | Health | Sector/Thematic |
52-Week High | $216.02 | $46.99 |
52-Week Low | $166.42 | $22.23 |
Enterprise Value | $28.82B | — |
Dividend Yield | 1.67% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Quest Diagnostics (DGX) trades at $207.35, showing minimal daily movement with a slight decline of 0.04%. The stock maintains a bullish technical stance with recent earnings beats and analyst consensus pointing to upside potential. Recent developments include New York State approval for Haystack MRD testing and strong momentum across diagnostic channels. Revenue growth accelerated to $11.04 billion in 2025 with consistent profitability margins around 9%.
DGX presents a balanced investment case with 38% analyst buy ratings and a $227.75 price target suggesting 10% upside. The company demonstrates steady revenue growth and operational efficiency, though elevated debt levels and policy risks require monitoring. Second quarter earnings on July 23, 2026, will be crucial for validating current momentum and growth trajectory.
PBW (Invesco WilderHill Clean Energy ETF) trades at $34.00, down 3.46% with a bearish technical signal from moving averages. The ETF shows oversold conditions with RSI readings below 30, while clean energy sector news highlights both volatility and growth potential driven by energy security concerns and data center demand. Recent articles note PBW's 34% year-to-date gains but caution about rate cycle sensitivity.
Outlook remains mixed with technical weakness offset by clean energy tailwinds. Investment opportunity lies in global energy transition trends, but risks include interest rate sensitivity and sector volatility. The ETF's performance is heavily influenced by macroeconomic factors rather than individual company fundamentals.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Quest Diagnostics Inc
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
Read more on DGX →About Invesco WilderHill Clean Energy ETF
PBW is an equal-weighted ETF that invests in U.S. companies leading the clean energy transition. It focuses on renewable energy, power conservation, and sustainable technologies like solar, wind, and energy storage.
Read more on PBW →
